| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 61.046 | 90.073 | 94.946 | 141.816 | 116.108 | 27.703 | 240.560 | 133.834 | 0 | 0 |
| Total Income - EUR | 61.053 | 90.074 | 94.946 | 141.816 | 116.108 | 27.703 | 240.560 | 133.834 | 0 | 0 |
| Total Expenses - EUR | 10.165 | 22.922 | 45.267 | 41.010 | 41.826 | 3.021 | 773 | 1.268 | 9.096 | 9.824 |
| Gross Profit/Loss - EUR | 50.888 | 67.153 | 49.680 | 100.806 | 74.283 | 24.682 | 239.787 | 132.565 | -9.096 | -9.824 |
| Net Profit/Loss - EUR | 49.057 | 64.450 | 46.831 | 96.551 | 70.799 | 23.850 | 232.714 | 129.028 | -9.096 | -9.824 |
| Employees | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dami Med Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 531 | 102 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 49.242 | 64.798 | 48.562 | 102.106 | 171.714 | 165.777 | 240.561 | 368.643 | 360.225 | 196.600 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 40.872 | 170.144 | 162.680 | 229.236 | 361.753 | 355.358 | 195.561 |
| Cash | 49.242 | 64.798 | 48.562 | 61.233 | 1.570 | 3.097 | 11.324 | 6.889 | 4.866 | 1.038 |
| Shareholders Funds | 49.111 | 64.504 | 46.884 | 96.603 | 165.531 | 155.233 | 232.763 | 362.513 | 352.318 | 189.750 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 662 | 397 | 1.678 | 5.503 | 6.183 | 10.544 | 7.798 | 6.130 | 7.907 | 6.850 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dami Med Consulting Srl